Generic AI Is a Commodity
Any company can buy the same foundation models. Running the same AI on the same data as competitors isn't differentiating — it's commodifying.
Generic AI knows that diabetes exists, what HbA1c is, and roughly how insulin works. Fine-tuned AI knows what that looks like in your specific patient population — and produces results no generic model can replicate.
Any company can buy the same foundation models. Running the same AI on the same data as competitors isn't differentiating — it's commodifying.
Fine-tuned AI trained on your clinical data and patient population produces capabilities a competitor can't replicate without your proprietary data.
A model trained on your EHR terminology, care pathways, and disease prevalence is clinically useful in ways a generic model never will be.
Measurable, documented, defensible results — across every dimension of clinical AI. Drag, click a card, or use the dots to explore each dimension.
Proprietary assets a competitor can't replicate easily.
Start a ConversationFine-tuned AI matters most when your edge depends on proprietary data a generic model has never seen.
Fine-tuned models that beat generic AI on clinical tasks are a real, defensible product differentiator.
Fine-tuned AI on your proprietary claims data delivers better risk stratification and fraud detection.
AI tuned to your clinical workflows outperforms generic AI on documentation and operational forecasting.
When AI is your value proposition, fine-tuned models are the moat generic foundation models can't match.
Generic models for generic problems. Fine-tuned models for the specific clinical and operational realities of your organisation.
Start a Conversation
100 Fastest Growth Companies
Global Spring Winner
Top App Development Company
AWS Partner Network
Google Cloud Partner
Highly Rated on Trustpilot
Verified Agency
Top App Development Company
ASSOCHAM Member
It depends on the task. Some fine-tuning approaches work well with relatively small, high-quality datasets. Others require larger volumes. We assess what you have during discovery and recommend the approach that will produce the best results given your data reality — which sometimes means a different technique than fine-tuning, and sometimes means a data augmentation strategy before tuning.
Patient data is de-identified before it is used in any training process, in compliance with HIPAA and applicable Indian data privacy regulations. De-identification is handled by us or in collaboration with your compliance team, and the process is documented for your regulatory records.
We run head-to-head evaluations on held-out clinical cases — comparing the fine-tuned model's outputs to the generic model's outputs, evaluated against clinical accuracy criteria defined with your subject matter experts. The improvement is measurable and documented before deployment.